A Bibliometric Analysis of Moderna mRNA-1273 Vaccine for COVID-19

Abstract

We performed the 1st bibliometric analysis of the Moderna mRNA-1273 vaccine (for COVID-19). On May 28, 2021, the data was retrieved from the Scopus database. In total, two hundred and three (n=203) documents are published about Moderna, majorly comprising of reviews (n=84) and articles (n=66). In all documents (reviews and articles only), 1110 authors have significantly contributed. The documents per author were 0.135, while authors per document were 7.4. The collaborative Index (CI) was 8.34. By Lotka's Law, we provided information about the frequency of authors. For example, 1021 authors were involved in one (n=1) publication. The total number of publications, h-index, m-index, g-index, and total citations for all authors are provided. The highest documents are published by the National Institutes of Health NIH (n-8) & Moderna Therapeutics (n=8 and the National Institute of Allergy and Infectious Diseases NIAID (n=7). Fifty-five (n=55) countries have significantly contributed to all publications. The highest documents are published by the United States (n=74), India (n=30), and the United Kingdom (n=16). By Biblioshiny, the co-authorship network is also presented. All documents are published in 118 different sources, majorly in Vaccines (n=6), Frontiers in Immunology (n=5), and New England Journal Of Medicine (n=4). We also provided the H-index, g-index, and m-index of all sources. The top ten (n-10) most cited documents are briefly discussed, while we provided a general overview of the publications by co-words analysis. On December 18, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Moderna COVID-19 (mRNA-1273) vaccine.